Director, Business Operations and Go-to-Market
EndeavourX, a fast-growing AI spinout in the healthtech domain, is seeking a Director to lead Business Operations and Go-to-Market strategy. This hybrid role involves driving cross-functional operational excellence, commercial engine building, and the operationalisation of AI use cases within clinical environments. The successful candidate will report directly to the CEO, managing high-stakes stakeholder relationships and interim Sales/CS leadership duties. It is a pivotal leadership position designed for a strategic operator experienced in regulated industries or scale-ups.
50k new jobs listed every day. Install TAL to find more jobs like this.

Experience
7-10 years
Function
Operations
Work mode
Hybrid, Singapore
Company
Tier 2
What you will work on
EndeavourX, a fast-growing AI spinout in the healthtech domain, is seeking a Director to lead Business Operations and Go-to-Market strategy. This hybrid role involves driving cross-functional operational excellence, commercial engine building, and the operationalisation of AI use cases within clinical environments. The successful candidate will report directly to the CEO, managing high-stakes stakeholder relationships and interim Sales/CS leadership duties. It is a pivotal leadership position designed for a strategic operator experienced in regulated industries or scale-ups.
TAL's take
Strategic Director-level role reporting to the CEO at a high-growth AI spinout with clear, high-impact responsibilities.
The JD provides a highly detailed breakdown of responsibilities across BizOps, GTM, and AI implementation, with clear reporting lines.
Must haves
- 7-10 years experience in business operations, GTM, strategy, or project management
- Proven experience in startups, scale-ups, or corporate spinouts
- Track record in leading cross-functional initiatives and large-scale operational rollouts
- Excellent communicator with strong senior-stakeholder management instincts
About the company
EndeavourX is a healthtech spinout, categorized as a mid-stage or growth-stage entity.